Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.
2.

Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion.

Simpkins F, Papadia A, Kunos C, Michener C, Frasure H, AbuShahin F, Mariani A, Bakkum-Gamez JN, Landrum L, Moore K, Thomas SG, Windhorn A, Rose PG.

Int J Gynecol Cancer. 2013 Jan;23(1):98-104. doi: 10.1097/IGC.0b013e318276d9b6.

PMID:
23221731
3.

Lymphovascular Space Invasion Portends Poor Prognosis in Low-Risk Endometrial Cancer.

dos Reis R, Burzawa JK, Tsunoda AT, Hosaka M, Frumovitz M, Westin SN, Munsell MF, Ramirez PT.

Int J Gynecol Cancer. 2015 Sep;25(7):1292-9. doi: 10.1097/IGC.0000000000000490.

4.

Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer--A pooled analysis of PORTEC 1 and 2 trials.

Bosse T, Peters EE, Creutzberg CL, J├╝rgenliemk-Schulz IM, Jobsen JJ, Mens JW, Lutgens LC, van der Steen-Banasik EM, Smit VT, Nout RA.

Eur J Cancer. 2015 Sep;51(13):1742-50. doi: 10.1016/j.ejca.2015.05.015. Epub 2015 Jun 3.

PMID:
26049688
5.

Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy.

Narayan K, Khaw P, Bernshaw D, Mileshkin L, Kondalsamy-Chennakesavan S.

Int J Gynecol Cancer. 2012 Feb;22(2):260-6. doi: 10.1097/IGC.0b013e318230c264.

PMID:
22080878
6.

Tumor size: a better independent predictor of distant failure and death than depth of myometrial invasion in International Federation of Gynecology and Obstetrics stage I endometrioid endometrial cancer.

Chattopadhyay S, Cross P, Nayar A, Galaal K, Naik R.

Int J Gynecol Cancer. 2013 May;23(4):690-7. doi: 10.1097/IGC.0b013e31828c85c6.

PMID:
23518862
7.

Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer.

Alexander-Sefre F, Singh N, Ayhan A, Thomas JM, Jacobs IJ.

Gynecol Oncol. 2004 Feb;92(2):653-9.

PMID:
14766262
8.

The impact of lymph vascular space invasion on recurrence and survival in patients with early stage endometrial cancer.

Loizzi V, Cormio G, Lorusso M, Latorre D, Falagario M, Demitri P, Scardigno D, Selvaggi LE.

Eur J Cancer Care (Engl). 2014 May;23(3):380-4. doi: 10.1111/ecc.12115. Epub 2013 Sep 23.

PMID:
24112088
9.

Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.

Singh P, Tripcony L, Nicklin J.

Int J Gynecol Cancer. 2012 Jan;22(1):115-22. doi: 10.1097/IGC.0b013e31822fa8bb.

PMID:
21997176
10.

Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.

Zhang GY, Wu LY, Li B, Huang MN, Zhang R, Li XG.

Eur J Obstet Gynecol Reprod Biol. 2013 Jul;169(2):309-16. doi: 10.1016/j.ejogrb.2013.02.025. Epub 2013 Mar 27.

PMID:
23540792
11.

Factors related to recurrence in non-obese women with endometrial endometrioid adenocarcinoma.

Panggid K, Cheewakriangkrai C, Khunamornpong S, Siriaunkgul S.

J Obstet Gynaecol Res. 2010 Oct;36(5):1044-8.

PMID:
21058438
12.

Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.

Alektiar KM, Venkatraman E, Chi DS, Barakat RR.

Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):111-7.

PMID:
15850910
13.

Lymphovascular space invasion does not predict vaginal relapses in stage I endometrioid adenocarcinoma of the endometrium.

Desrosiers L, Fadare O, Xiao ZF, Dresser K, Wang SA.

Ann Diagn Pathol. 2008 Apr;12(2):112-7. doi: 10.1016/j.anndiagpath.2007.05.009. Epub 2007 Oct 24.

PMID:
18325471
14.

Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer.

Guntupalli SR, Zighelboim I, Kizer NT, Zhang Q, Powell MA, Thaker PH, Goodfellow PJ, Mutch DG.

Gynecol Oncol. 2012 Jan;124(1):31-5. doi: 10.1016/j.ygyno.2011.09.017. Epub 2011 Oct 26.

15.

The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.

Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA.

Gynecol Oncol. 2006 Oct;103(1):87-93. Epub 2006 Mar 20.

PMID:
16545441
16.

Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.

Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.

Gynecol Oncol. 2005 Mar;96(3):651-7.

PMID:
15721407
17.

The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.

Cirisano FD Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.

Gynecol Oncol. 2000 Apr;77(1):55-65.

PMID:
10739691
18.

Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: a multi-institution study.

Elshaikh MA, Al-Wahab Z, Mahdi H, Albuquerque K, Mahan M, Kehoe SM, Ali-Fehmi R, Rose PG, Munkarah AR.

Gynecol Oncol. 2015 Feb;136(2):235-9. doi: 10.1016/j.ygyno.2014.12.012. Epub 2014 Dec 12.

PMID:
25511158
19.

Lymphovascular space invasion is highly associated with lymph node metastasis and recurrence in endometrial cancer.

Hahn HS, Lee IH, Kim TJ, Lee KH, Shim JU, Kim JW, Lim KT.

Aust N Z J Obstet Gynaecol. 2013 Jun;53(3):293-7. doi: 10.1111/ajo.12089. Epub 2013 Apr 22.

PMID:
23600915
20.

Satellite lymphovascular space invasion: An independent risk factor in early stage cervical cancer.

Pol FJ, Zusterzeel PL, van Ham MA, Kuijpers DA, Bulten J, Massuger LF.

Gynecol Oncol. 2015 Sep;138(3):579-84. doi: 10.1016/j.ygyno.2015.06.035. Epub 2015 Jun 28.

PMID:
26126782

Supplemental Content

Support Center